Full text is available at the source.
Abstract
Long COVID guidelines provide a solid basis for future updates and trials.
- Future updates may benefit from integrating patients' reinfection history.
- Incorporating reproducible biological features could enhance guideline interpretation.
- Equity-relevant risks are associated with identifying patients who may benefit most from interventions.
Simplified